title: Intradermal Hepatitis B Vaccine: Pilot study.
abstract: Intramuscular administration of hepatitis B (HB) vaccine is safe and efficacious, but its cost has limited its availability. In this pilot study, 49 of 56 participants who received 2 μg of intradermal (ID) HB vaccine (one tenth the intramuscular dose) at the beginning of administration, at 1 month, and at 6 months developed protective levels of antibody to HB surface antigen. Although questions remain, the cost savings of this technique make it worth considering.
authors.forename: D G
authors.initials: DG
authors.lastname: Ruddock
authors.forename: A
authors.initials: A
authors.lastname: Dickson